Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasser Mikhail

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
The American Journal of Medicine|May 3, 2006
Does testosterone have a role in erectile function?Nasser Mikhail
Current Cardiology Reviews|September 20, 2017
Effects of Evolocumab on Cardiovascular EventsNasser Mikhail
Southern Medical Journal|March 28, 2008
Why should we avoid the use of rosiglitazone?Nasser Mikhail
Current Drug Safety|January 23, 2014
Safety of canagliflozin in patients with type 2 diabetesNasser Mikhail
Current Drug Delivery|June 24, 2011
Quick-release bromocriptine for treatment of type 2 diabetesNasser Mikhail
Vascular Health and Risk Management|April 2, 2009
Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potentialNasser Mikhail
JAMA|October 9, 2002
Insulin resistance and HIV-related lipoatrophyNasser Mikhail
Archives of Internal Medicine|February 13, 2003
The use of niacin in diabetes mellitusNasser Mikhail
Archives of Internal Medicine|January 16, 2008
Cardiovascular safety of low-dose rosiglitazoneNasser Mikhail
World Journal of Diabetes|December 30, 2016
Place of technosphere inhaled insulin in treatment of diabetesNasser Mikhail
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
The American Journal of Medicine|May 3, 2006
Does testosterone have a role in erectile function?Nasser Mikhail
Current Cardiology Reviews|September 20, 2017
Effects of Evolocumab on Cardiovascular EventsNasser Mikhail
Southern Medical Journal|March 28, 2008
Why should we avoid the use of rosiglitazone?Nasser Mikhail
Current Drug Safety|January 23, 2014
Safety of canagliflozin in patients with type 2 diabetesNasser Mikhail
Current Drug Delivery|June 24, 2011
Quick-release bromocriptine for treatment of type 2 diabetesNasser Mikhail
Vascular Health and Risk Management|April 2, 2009
Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potentialNasser Mikhail
JAMA|October 9, 2002
Insulin resistance and HIV-related lipoatrophyNasser Mikhail
Archives of Internal Medicine|February 13, 2003
The use of niacin in diabetes mellitusNasser Mikhail
Archives of Internal Medicine|January 16, 2008
Cardiovascular safety of low-dose rosiglitazoneNasser Mikhail
World Journal of Diabetes|December 30, 2016
Place of technosphere inhaled insulin in treatment of diabetesNasser Mikhail
Pageof 6